Lung Cancer Clinical Trials | Norton Healthcare Louisville, Ky.

Lung Cancer Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. Our lung cancer clinical trials give patients access to new and innovative treatments.

Current clinical trials often include studies for non small cell lung cancer and innovative immunotherapy approaches.

Learn more about participating in a clinical trial at Norton Healthcare.

Active lung cancer clinical trials at Norton Cancer Institute include:

Lung Cancer

Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer

Lung Cancer

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study Of Chemoradiation Versus Chemoradiation Plus Atezolizumab

Lung Cancer

A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinu

Lung Cancer

A Phase II Multi Center Study of BGB324 in Combination with Pembrolizumab in Patients with Previously Treated Advanced Adenocarcinoma of the Lung

Lung Cancer

A Phase 3 Study of Pembrolizumab (MK-3475) in Combination with Concurrent Chemoradiation Therapy Followed by Pembrolizumab with or without Olaparib vs Concurrent Chemoradiation Therapy Followed by Dur

Lung Cancer

A Phase III, Open-label, Randomized Study of Osimertinib with or without Platinum Plus Pemetrexed Chemotherapy, as First-line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutatio

Lung Cancer

A Phase 2 Study to Evaluate the Safety and Efficacy of AB122 Monotherapy, AB154 in Combination with AB122, and AB154 in Combination with AB122 and AB928 in Front-Line, Non-Small Cell Lung Cancer

Lung Cancer

A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Study to Determine the Efficacy of Adjuvant Durvalumab in Combination with Platinum-based Chemotherapy in Completely Resected Sta

Lung Cancer

A Phase Ib/II, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Glumetinib (SCC244), a Selective MET Inhibitor in Patients with Advanced Non-Small Cell Lung Cancer Harboring MET-al

Lung Cancer

Prospective, Interventional Pilot Study of Mobile Devices and Digital Applications to Detect Early Pneumonitis and Other Pulmonary Adverse Events in Unresectable Stage III Non-Small Cell Lung Cancer P

Miscellaneous Malignancies

A Phase 1 Dose Escalation and Expanded Cohort Study of PF-06821497 in the treatment of adult patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC), Castration Resistant Prostate Cancer (CRPC

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3500

Bike to Beat Cancer rider, fundraiser and volunteer Mike Farmer supports other survivors and those we’ve lost

If you have ever been to a Bike to Beat Cancer training ride or event, chances are you have met one of Bike to Beat Cancer’s most dedicated riders, Mike Farmer. Mike has ridden in […]

Read Full Story

Art therapy patient shares stories of hope and healing

Daniel Bulleit knows a lot about the power of art. His interest began at age 5, when he would draw pictures to stand out among a family that would grow to include 11 siblings. He […]

Read Full Story

Swollen lymph nodes are a normal and harmless COVID-19 vaccine side effect

The COVID-19 vaccine is causing swollen lymph nodes in many, but the harmless side effect is causing alarm as some mistake the temporary underarm lump for a tumor. “The concern is understandable, as a lump […]

Read Full Story

If you’ve been putting off cancer screenings, here’s your guide to catching up

Cancer screening tests were put off by many while we stayed safer at home. Delays of just a few months in detecting various forms of cancer can make treatment more difficult and reduce chances of […]

Read Full Story

Norton Specialty Rehabilitation Center gets national certification for cancer rehab

Norton Specialty Rehabilitation Center – St. Matthews has been designated a Physiological Oncology Rehabilitation Institute (PORi) Center of Excellence. This is the only national certification in cancer rehabilitation, which offers therapies designed to improve physical […]

Read Full Story
Related Stories

Bike to Beat Cancer rider, fundraiser and volunteer Mike Farmer supports other survivors and those we’ve lost

If you have ever been to a Bike to Beat Cancer training ride or event, chances are you have met one of Bike to Beat Cancer’s most dedicated riders, Mike Farmer. Mike has ridden in […]

Read Full Story

Art therapy patient shares stories of hope and healing

Daniel Bulleit knows a lot about the power of art. His interest began at age 5, when he would draw pictures to stand out among a family that would grow to include 11 siblings. He […]

Read Full Story

Swollen lymph nodes are a normal and harmless COVID-19 vaccine side effect

The COVID-19 vaccine is causing swollen lymph nodes in many, but the harmless side effect is causing alarm as some mistake the temporary underarm lump for a tumor. “The concern is understandable, as a lump […]

Read Full Story

If you’ve been putting off cancer screenings, here’s your guide to catching up

Cancer screening tests were put off by many while we stayed safer at home. Delays of just a few months in detecting various forms of cancer can make treatment more difficult and reduce chances of […]

Read Full Story

Norton Specialty Rehabilitation Center gets national certification for cancer rehab

Norton Specialty Rehabilitation Center – St. Matthews has been designated a Physiological Oncology Rehabilitation Institute (PORi) Center of Excellence. This is the only national certification in cancer rehabilitation, which offers therapies designed to improve physical […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.